Workout Booster
Natural health product licensed in Canada
- Licence holder
- Stalco Inc.
- NPN or DIN-HM
- 80085456
- Status
- Inactive licence
- Licence date
- 23 May 2018
- Revision date
- 13 August 2018
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Magnésium Source : Citrate de magnésium | 10 milligramme | 20,000 µg |
| L-arginine Source : Monohydrochlorure de L-arginine | 342.58 milligramme | Not calculated |
| L-arginine Source : Alpha-cétoglutarate de L-arginine | 342.58 milligramme | Not calculated |
| (S)-N5-Carbamoylornithine Source : Ester d'éthyle de citrulline | 47 milligramme | Not calculated |
| (S)-N5-Carbamoylornithine Source : Malate de citrulline | 47 milligramme | Not calculated |
Non-medicinal ingredients
Hypromellose, Cellulose microcristalline, Stéarate de magnésium, Eau
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps in the development and maintenance of bones and teeth. Helps in tissue formation. Helps to maintain proper muscle function. Helps to maintain proper muscle function, including the heart muscle. Source of/An electrolyte for the maintenance of good health. Helps in energy metabolism, tissue formation and bone development. Helps to maintain normal electrolyte balance. Workout supplement. Athletic support. Source of (an) amino acid(s) involved in muscle protein synthesis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Some people may experience gastrointestinal discomfort (such as diarrhea) .
- Contre-indications
If you suffer from a cardiovascular disease, consult your health care practitioner for use beyond 6 weeks. Do not use if you have had a heart attack/myocardial infarction.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner if your cardiovascular condition worsens. Consult a health care practitioner prior to use if you have a renal/kidney disease, if you are following a low protein diet, if you suffer from a cardiovascular disease and are attempting an increase in physical activity, or if you are taking medication for cardiovascular diseases, erectile dysfunction, and/or blood thinners.
Source
Official Health Canada record, licence 80085456
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2018. Photograph the packaging to check whether it has changed. Photograph the packaging